Remove 2026 Remove Healthcare Provider Remove Pharma Remove Prescription
article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

article thumbnail

Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts

Clarivate

Starting in 2026, the first ten self-administered Part D drugs in the law’s cross hairs will receive price cuts of 38%-79%. With the passage of the Inflation Reduction Act (IRA), the United States government gained the ability to directly negotiate drug prices with manufacturers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. Overall, the industry is steadily becoming more consolidated and is likely to continue to do so.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Since buying the chain, Amazon has made strategic expansions of its brick-and-mortar locations ( Connecticut , San Francisco , and Milwaukee ), increased IDN partnerships for specialty referrals to 18, and introduced healthcare-focused subscription services, including One Medical and RxPass. Source: News reports and company releases.

Retail 52